NasdaqGM:OMERPharmaceuticals
Omeros (OMER) Stock Jumps On YARTEMLEA Profit Breakthrough
Omeros stock ripped 26.4% higher to US$17.33 on Thursday, capping a sharp multi week rebound that already had the shares up strongly before earnings. Traders clearly rushed to price in a cleaner story. The headline from the quarter is simple. YARTEMLEA’s first full commercial quarter produced US$28.5m in net sales and helped deliver positive adjusted net income instead of another deep loss.
The market is trading this as a sentiment reset on profitability and cash generation. The question now...